Overview
Corticotropin-releasing hormone (CRH) is a key regulatory hormone of the hypothalamic–pituitary–adrenal (HPA) axis and plays a central role in managing the body’s response to stress. CRH stimulates the pituitary gland to release adrenocorticotropic hormone (ACTH), which in turn acts on the adrenal cortex to promote the synthesis and secretion of glucocorticoids, particularly cortisol.
Through this axis, Corticotropin-releasing hormone helps maintain physiological balance during stress. In addition to its endocrine role, CRH influences the gastrointestinal system by inhibiting hunger and also affects the reproductive system. During pregnancy, the placenta and its accessory membranes become major sites of CRH synthesis and secretion.
Symptoms
Alterations in Corticotropin-releasing hormone levels are associated with a variety of clinical manifestations. Reduced CRH activity may contribute to adrenal insufficiency (hypoadrenalism), chronic fatigue, anorexia, weight loss, and impaired stress response. Low CRH levels have also been associated with elevated serum leptin and interleukin-6 (IL-6) levels, leading to sustained anorexia and weight loss.
Neurological and psychiatric symptoms linked to CRH imbalance include sleep disturbances, memory impairment, poor concentration, anxiety-related disorders, major depression, and eating disorders such as anorexia nervosa. CRH dysregulation has also been implicated in neurodegenerative conditions, including Alzheimer’s disease, Parkinson’s disease, and progressive supranuclear palsy.
Causes
Corticotropin-releasing hormone imbalance can arise due to dysfunctions of the hypothalamic–pituitary–adrenal axis. Conditions such as chronic renal failure, chronic fatigue, and adrenal insufficiency are associated with altered CRH secretion. Reduced CRH production may also be involved in chronic fatigue syndrome, also known as myalgic encephalomyelitis, where patients experience persistent fatigue along with cognitive and sleep-related problems.
In pregnancy, physiological changes lead to increased placental production of CRH, which plays a role in fetal development and preparation for labor.
Risk Factors
Patients with suspected HPA axis disorders, chronic renal failure, chronic fatigue, adrenal insufficiency, or unexplained neuropsychiatric symptoms are at increased risk of CRH imbalance. Individuals with stress-related disorders, mood disorders, eating disorders, or neurodegenerative diseases may also demonstrate altered CRH activity.
During pregnancy, changes in placental CRH production influence maternal and fetal endocrine function and may affect the timing of labor.
Prevention and Diagnostic Approach
Corticotropin-releasing hormone assessment is primarily used in evaluating disorders of cortisol excess or deficiency. Blood samples for CRH testing are collected after fasting, using 3.0 ml of blood in an EDTA (lavender-capped) tube.
The normal reference value provided is approximately 1.64 ± 0.43 pmol/L, though this may vary depending on laboratory methods and assay kits.
A CRH stimulation test is used to differentiate causes of hypercortisolism:
- Baseline blood samples for ACTH and cortisol are collected
- CRH is administered intravenously at a dose of 1 mg/kg
- Blood samples for ACTH and cortisol are collected at 15, 30, 60, 90, and 120 minutes
Interpretation:
- A peak increase in serum cortisol of more than 20% and plasma ACTH greater than 50% suggests Cushing’s disease
- An increase of 35–50% in ACTH and 20% in cortisol from baseline indicates a pituitary origin of hypercortisolemia
Clinical Significance
Corticotropin-releasing hormone plays a crucial role in stress regulation, endocrine balance, and reproductive physiology. Its measurement and stimulation testing are valuable tools in diagnosing disorders of the HPA axis, particularly in distinguishing pituitary-dependent and adrenal causes of cortisol imbalance. CRH is also significant in pregnancy, where placental CRH regulates blood flow, prostaglandin production, fetal adrenal cortisol and dehydroepiandrosterone synthesis, and myometrial contractility, thereby contributing to the onset of labor.
